Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use challenges during the college transition period. Digital tools like this are being studied because they can reach large student populations at low cost and high accessibility. Results from this trial provide evidence on whether app-based interventions can meaningfully improve real-world mental health and substance use outcomes in young adults.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides evidence on whether a student-centered mobile intervention can effectively address the critical clinical need for mental health and substance use support during the high-risk university transition period. The scalability and accessibility of digital interventions like Minder are particularly significant given the documented gap between mental health treatment demand and available clinical resources for this population. Positive efficacy data would support the integration of evidence-based mobile apps into university health systems as a cost-effective supplement to traditional mental health services.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 The Minder app study addresses a genuine clinical need—early intervention during the high-risk university transition period—but several factors warrant caution before broad implementation in practice. While mobile health interventions show promise for reach and scalability, this RCT’s effectiveness depends heavily on adherence rates, baseline risk stratification of participants, and whether observed improvements persist beyond the study period, none of which are fully detailed in the available abstract. Cannabis-using students represent a subset of this population with particular vulnerabilities to both mental health deterioration and problematic use escalation, yet the abstract does not specify how substance use outcomes were measured or whether cannabis specifically was adequately captured alongside other substances. As clinicians considering recommending digital tools to students, the practical takeaway is to view Minder and similar apps as adjuncts to, rather than replacements for, direct assessment and therapeutic relationship—particularly important for students disclosing cannabis use, who benefit from motivational interviewing and personalized risk discussion that requires human clinical presence.